iX Biopharma Ltd. (SG:42C) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
iX Biopharma Ltd has announced a reduction in net proceeds from its Rights cum Warrants Issue to $1.55 million after a significant shareholder, Anson Properties, was unable to fulfill its subscription commitment due to timing of funds. Anson Properties still intends to invest in the company within the next four to six weeks. The company reassures that this event will not materially impact operations or finances and will keep the market updated through SGXNET.
For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue